When was Subsense founded?

Subsense was founded in 2022 and raised its 1st funding round 3 years after it was founded.

Where is Subsense located?

Subsense is headquartered in Covina, United States.

Who is the current CEO of Subsense?

Tetiana Aleksandrova of Subsense. They have also founded 1 company.

How many employees does Subsense have?

As of Sep 30, 2026, the latest employee count at Subsense is 43.

Is Subsense a funded company?

Subsense is a funded company, having raised a total of $27M across 2 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Feb 18, 2025.

When was the latest funding round of Subsense?

Subsense's latest funding was a $***** Seed round on Dec 11, 2025, with participation from 1 investor. Its primary sector is Neurology. In United States, the Neurology sector has seen $4.57B in funding in 2026 to date.

Where does Subsense rank among its competitors?

Subsense ranks 9th amongst 90 active competitors, of which 28 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was BlueWind Medical, which secured $47.8M in May, 2026.

Who are the top competitors of Subsense?

Subsense's top competitors include ElectroCore, Science and ONWARD. Among them, BlueWind Medical secured the most recent funding round in May, 2026.

Subsense - 2026 Company Profile, Team, Funding & Competitors

Subsense is a seed company based in Covina (United States), founded in 2022 by Tetiana Aleksandrova. It operates as a Developer of non-surgical brain-computer interfaces using biocompatible nanoparticles. Subsense has raised $27M in funding from Golden Falcon Capital. The company has 90 active competitors, including 28 funded and 7 that have exited. Its top competitors include companies like ElectroCore, Science and ONWARD.

Company Details

Developer of non-surgical brain-computer interfaces using biocompatible nanoparticles. This technology facilitates the recording and stimulation of neural activity, offering potential applications in treating neurological disorders, enhancing human-machine interaction, and improving diagnostic capabilities. The system's non-invasive nature ensures a safer and more accessible approach compared to traditional methods. The biocompatible nanoparticles are designed for seamless integration with the brain, enabling accurate signal transmission without adverse effects. The resulting brain-computer interface transforms thoughts into digital control, providing increased independence for individuals with paralysis and neurological conditions.

Key Metrics

Founded Year

2022

Location

Covina, United States

Stage

Seed

Total Funding

$27M in 2 rounds

Latest Funding Round

Seed, Dec 11, 2025, $*****

Investors

Golden Falcon Capital

Ranked

9^th among 90 active competitors

Employee Count

43 as on Sep 30, 2026

Similar Companies

ElectroCore & 96 more

View Subsense's full profile

Subsense has raised a total funding of $27M over 2 rounds. Its first funding round was on Feb 18, 2025. Its latest funding round was a Seed round on Dec 11, 2025 for $*****. 1 investor participated in its latest round. Subsense has 1 institutional investor.

Here is the list of recent funding rounds of Subsense:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 11, 2025	6895408	Seed	4241579	6049174	3011496	2082707
Feb 18, 2025	6391821	Seed	5128771	4111956	Golden Falcon Capital	8583335

Access funding benchmarks and valuations. Sign up today!

View details of Subsense's funding rounds and investors

The founders of Subsense is Tetiana Aleksandrova. Tetiana Aleksandrova is the CEO of Subsense.

Here are the details of Subsense's key team members:

Tetiana Aleksandrova: Founder & CEO of Subsense.
Contact Info: 1 email address

View details of Subsense's Founder profiles and Board Members

Subsense's employee count trend

Subsense has 43 employees as of Sep 26. Here is Subsense's employee count trend over the years:

Uncover Subsense's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Subsense include ElectroCore, Science and ONWARD. Here is the list of Top 10 competitors of Subsense, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	ElectroCore 2005, Basking Ridge (United States), Public	Developer of non-invasive vagus nerve stimulation devices	$161M	Core Ventures Group, Easton Capital Investment Group ... & 6 others	69/100
2nd	Science 2021, Alameda (United States), Series C	Provider of online science magazine	$490M	Khosla Ventures, RAA Capital & 11 others	66/100
3rd	ONWARD 2014, Eindhoven (Netherlands), Public	Developer of a therapeutic device for spinal cord injuries	$35M	Olympic Investment, Invest-NL & 18 others	63/100
4th	Synchron 2016, Brooklyn (United States), Series D	Developer of implantable bioelectronics for the treatment of neurological conditions	$345M	Arch Venture Partners, Khosla Ventures & 33 others	63/100
5th	Nalu Medical 2014, Carlsbad (United States), Acquired	Developer of a neurostimulation system for managing intractable chronic pain	$231M	Gilde Healthcare, MVM & 9 others	61/100
6th	Neurovalens 2013, Belfast (United Kingdom), Series A	Developer of non-invasive neurostimulation products	$26.1M	IQ Capital, ACF Investors & 57 others	59/100
7th	BlueWind Medical 2010, Herzliya (Israel), Series B	Developer of neurostimulation device for the treatment of overactive bladder	$112M	ConvaTec, Rainbow Medical	56/100
8th	Openwater 2016, San Francisco (United States), Series C	Provider of imaging technologies for medical diagnosis and treatments	$100M	Bold Capital Partners, Khosla Ventures & 10 others	51/100
9th	Subsense 2022, Covina (United States), Seed	Developer of non-surgical brain-computer interfaces using biocompatible nanoparticles	$27M	Golden Falcon Capital	49/100
10th	Atlantic Therapeutics 2013, Oranmore (Ireland), Acquired	Developer of a non-invasive wearable device for pelvic floor strengthening and nerve stimulation products	$70.6M	Life Sciences Partners, Western Development Commission ... & 10 others	48/100